Literature DB >> 22306545

[Two cases of thiopurine-induced acute pancreatitis in inflammatory bowel disease].

Jun Nishikawa1, Takahiko Kudo, Takako Miyazaki, Hiroshi Mihara, Akira Ueda, Takayuki Ando, Shinya Kajiura, Haruka Fujinami, Kohei Ogawa, Ayumu Hosokawa, Toshiro Sugiyama.   

Abstract

Thiopurine drugs have been widely used in the treatment of inflammatory bowel disease. However, their use is limited by adverse effect that can lead to cessation of therapy. We report 2 cases of thiopurine-induced acute pancreatitis in patients with inflammatory bowel disease. Both patients complained of abdominal pain, showed elevated pancreatic enzymes, and swollen pancreases on computed tomography. The patients' signs and symptoms resolved uneventfully after withdrawal of the thiopurine drugs. Although the mechanism of thiopurine-induced pancreatitis remains unclear, close monitoring and early recognition of acute pancreatitis is important in the management of new thiopurine users.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306545

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  1 in total

1.  Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis.

Authors:  Nobuyuki Miyake; Takafumi Ando; Kazuhiro Ishiguro; Osamu Maeda; Osamu Watanabe; Yutaka Hirayama; Keiko Maeda; Kazuhiro Morise; Masanobu Matsushita; Kazuhiro Furukawa; Kohei Funasaka; Masanao Nakamura; Ryoji Miyahara; Naoki Ohmiya; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.